TORIPALIMAB

Search structure
Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 8JXN261VVA

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Programmed cell death protein 1 antagonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 4 D009369 ClinicalTrials
Nasopharyngeal Carcinoma 4 D000077274 FDA
Nasopharyngeal Carcinoma 4 D000077274 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Nasopharyngeal Neoplasms 3 D009303 ClinicalTrials
Carcinoma, Hepatocellular 3 D006528 ClinicalTrials
Urinary Bladder Neoplasms 3 D001749 ClinicalTrials
Cholangiocarcinoma 3 D018281 ClinicalTrials
Adenocarcinoma 3 D000230 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Cholangiocarcinoma 3 D018281 ClinicalTrials
Urinary Bladder Neoplasms 3 D001749 ClinicalTrials
Urinary Bladder Neoplasms 3 D001749 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Carcinoma, Neuroendocrine 3 D018278 ClinicalTrials
Triple Negative Breast Neoplasms 3 D064726 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Lymphoma 3 D008223 ClinicalTrials
Hodgkin Disease 3 D006689 ClinicalTrials
Small Cell Lung Carcinoma 3 D055752 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Liver Neoplasms 2 D008113 ClinicalTrials
Liver Neoplasms 2 D008113 ClinicalTrials
Gestational Trophoblastic Disease 2 D031901 ClinicalTrials
Head and Neck Neoplasms 2 D006258 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Histiocytoma, Malignant Fibrous 2 D051677 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Biliary Tract Neoplasms 2 D001661 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Biliary Tract Neoplasms 2 D001661 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Granuloma, Lethal Midline 2 D006103 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Thyroid Neoplasms 2 D013964 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Hypopharyngeal Neoplasms 2 D007012 ClinicalTrials
Salivary Gland Neoplasms 2 D012468 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 2 D000077195 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Hypopharyngeal Neoplasms 2 D007012 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Carcinoma 2 D002277 ClinicalTrials
Mouth Neoplasms 1 D009062 ClinicalTrials
Epstein-Barr Virus Infections 1 D020031 ClinicalTrials
Colonic Neoplasms 1 D003110 ClinicalTrials
Thrombosis 1 D013927 ClinicalTrials
Liposarcoma 1 D008080 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297843
FDA SRS 8JXN261VVA
CONTENTS